Matches in SemOpenAlex for { <https://semopenalex.org/work/W2600547533> ?p ?o ?g. }
Showing items 1 to 65 of
65
with 100 items per page.
- W2600547533 abstract "Abstract The development of biomedical technologies and devices and their translation to the healthcare market requires a strong foundation in science and engineering, an understanding of clinical need, and well-honed entrepreneurial skills. Tulane University’s Bioinnovation PhD program was initiated in 2012 through the National Science Foundation’s Integrative Graduate Education and Research Training (IGERT) grant mechanism to provide emerging entrepreneurial scientists and engineers with the skills needed to bring research from “bench to bedside.” A hallmark of the program is a summer internship at the Food and Drug Administration (FDA) in the Division of Postmarket Surveillance – this is a Division in the Office of Surveillance and Biometrics of the Center for Devices and Radiological Health (CDRH). All degree candidates spend the summer working at the FDA in Silver Spring, MD after the first year of academic study to understand the practical and regulatory considerations that are required for the successful development of biomedical technologies and devices. Over the past three years, twelve fellows in three cohorts have participated in this summer internship program. The internships were a first for FDA; as such, expectations about what could be accomplished over a 12-week period were minimal. What occurred in the first couple of years was remarkable: Bioinnovation fellows were given considerable latitude and opportunity to discover and work on real world issues that the FDA needed to address. Fellows matriculated through the FDA along a path of relatively unstructured discovery, wherein they learned about the agency and the processes and issues associated with product regulatory practices. Likewise, the agency came to realize the value of an exploratory approach to orientation and training that is currently under consideration for new FDA analysts. The FDA internship has also proven to be influential to the professional growth of the graduate fellows. They found particular value in their role as “active witnesses” to the agency’s Signal Review Meetings, where they were able to observe, reflect and follow up with professionals on the decision making process associated with the adverse effects of a medical device. These interactions taught them how to network and learn through observation and to work within the confines of a hierarchical non-academic organization. The process also challenged analysts to expand their understanding of what is possible by considering new approaches to confronting regulatory issues." @default.
- W2600547533 created "2017-04-07" @default.
- W2600547533 creator A5001313702 @default.
- W2600547533 creator A5004379923 @default.
- W2600547533 creator A5011521796 @default.
- W2600547533 creator A5034022413 @default.
- W2600547533 date "2016-07-06" @default.
- W2600547533 modified "2023-09-27" @default.
- W2600547533 title "Opportunity to Grow and Explore: Lessons from a Bioinnovation Graduate Student Summer Internship Program at the U.S. Food and Drug Administration" @default.
- W2600547533 doi "https://doi.org/10.18260/p.25839" @default.
- W2600547533 hasPublicationYear "2016" @default.
- W2600547533 type Work @default.
- W2600547533 sameAs 2600547533 @default.
- W2600547533 citedByCount "0" @default.
- W2600547533 crossrefType "proceedings-article" @default.
- W2600547533 hasAuthorship W2600547533A5001313702 @default.
- W2600547533 hasAuthorship W2600547533A5004379923 @default.
- W2600547533 hasAuthorship W2600547533A5011521796 @default.
- W2600547533 hasAuthorship W2600547533A5034022413 @default.
- W2600547533 hasBestOaLocation W26005475331 @default.
- W2600547533 hasConcept C108170787 @default.
- W2600547533 hasConcept C127413603 @default.
- W2600547533 hasConcept C144024400 @default.
- W2600547533 hasConcept C17744445 @default.
- W2600547533 hasConcept C18762648 @default.
- W2600547533 hasConcept C2985790989 @default.
- W2600547533 hasConcept C3018890749 @default.
- W2600547533 hasConcept C36289849 @default.
- W2600547533 hasConcept C39549134 @default.
- W2600547533 hasConcept C509550671 @default.
- W2600547533 hasConcept C540751848 @default.
- W2600547533 hasConcept C71924100 @default.
- W2600547533 hasConcept C78519656 @default.
- W2600547533 hasConcept C99454951 @default.
- W2600547533 hasConceptScore W2600547533C108170787 @default.
- W2600547533 hasConceptScore W2600547533C127413603 @default.
- W2600547533 hasConceptScore W2600547533C144024400 @default.
- W2600547533 hasConceptScore W2600547533C17744445 @default.
- W2600547533 hasConceptScore W2600547533C18762648 @default.
- W2600547533 hasConceptScore W2600547533C2985790989 @default.
- W2600547533 hasConceptScore W2600547533C3018890749 @default.
- W2600547533 hasConceptScore W2600547533C36289849 @default.
- W2600547533 hasConceptScore W2600547533C39549134 @default.
- W2600547533 hasConceptScore W2600547533C509550671 @default.
- W2600547533 hasConceptScore W2600547533C540751848 @default.
- W2600547533 hasConceptScore W2600547533C71924100 @default.
- W2600547533 hasConceptScore W2600547533C78519656 @default.
- W2600547533 hasConceptScore W2600547533C99454951 @default.
- W2600547533 hasLocation W26005475331 @default.
- W2600547533 hasOpenAccess W2600547533 @default.
- W2600547533 hasPrimaryLocation W26005475331 @default.
- W2600547533 hasRelatedWork W1787952992 @default.
- W2600547533 hasRelatedWork W2024385249 @default.
- W2600547533 hasRelatedWork W2081665633 @default.
- W2600547533 hasRelatedWork W2128468443 @default.
- W2600547533 hasRelatedWork W2418986779 @default.
- W2600547533 hasRelatedWork W2556225510 @default.
- W2600547533 hasRelatedWork W2566857522 @default.
- W2600547533 hasRelatedWork W2748952813 @default.
- W2600547533 hasRelatedWork W2899084033 @default.
- W2600547533 hasRelatedWork W2187788756 @default.
- W2600547533 isParatext "false" @default.
- W2600547533 isRetracted "false" @default.
- W2600547533 magId "2600547533" @default.
- W2600547533 workType "article" @default.